Vise Technologies’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Vise Technologies's LLY Position: Q2 2026 in Review
Vise Technologies increased its Eli Lilly (LLY) stake by 46% in Q2 2026, buying an estimated $11M and bringing the position to 34,353 shares worth $41.2M. The position accounts for 0.47% of the portfolio, ranked #46.
Vise Technologies first reported a position in LLY in Q1 2022 and has held it in 17 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Vise Technologies held 34,353 shares of Eli Lilly worth $41.2M as of Q2 2026.
- Vise Technologies bought 10,795 Eli Lilly shares in Q2 2026, an estimated $11M.
- Eli Lilly made up 0.47% of Vise Technologies's portfolio in Q2 2026, its #46 holding.
- Vise Technologies first reported a position in Eli Lilly in Q1 2022 and has held it in 17 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.